| Product NDC: | 25021-816 | 
| Proprietary Name: | Leucovorin | 
| Non Proprietary Name: | leucovorin calcium | 
| Active Ingredient(s): | 350 mg/17.5mL & nbsp; leucovorin calcium | 
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS | 
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 25021-816 | 
| Labeler Name: | Sagent Pharmaceuticals | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA200855 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20120915 | 
| Package NDC: | 25021-816-30 | 
| Package Description: | 1 VIAL in 1 CARTON (25021-816-30) > 17.5 mL in 1 VIAL | 
| NDC Code | 25021-816-30 | 
| Proprietary Name | Leucovorin | 
| Package Description | 1 VIAL in 1 CARTON (25021-816-30) > 17.5 mL in 1 VIAL | 
| Product NDC | 25021-816 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | leucovorin calcium | 
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION | 
| Route Name | INTRAMUSCULAR; INTRAVENOUS | 
| Start Marketing Date | 20120915 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Sagent Pharmaceuticals | 
| Substance Name | LEUCOVORIN CALCIUM | 
| Strength Number | 350 | 
| Strength Unit | mg/17.5mL | 
| Pharmaceutical Classes | Folate Analog [EPC],Folic Acid [Chemical/Ingredient] |